Nicole Mayer-Hamblett, PhD

Professor
University of Washington

Poster(s):

• (35) Approaches that use historical controls to meet modern needs in cystic fibrosis clinical trials
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (43) CFTR Modulator Induced Sweat Chloride Changes Across the Cystic Fibrosis Population from the CHEC-SC Study: 2022 Update
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (261) Concentrations of elexacaftor/tezacaftor/ivacaftor across the cystic fibrosis population: interim analysis of the CHEC-Pharmacokinetics study
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (694) Greater Reductions in Sweat Chloride with CFTR Modulator Use are Associated with Improved Clinical Outcomes
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET